Works by Kariyama, Kazuya

Results: 91

Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

Published in:

Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192

By:

Hatanaka, Takeshi;
Yata, Yutaka;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Kakizaki, Satoru;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Koshiyama, Yuichi;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi

Publication type:

Article

Factors Affecting an Increase in Spleen Volume and Association of Spleen Volume Variation with the Clinical Outcomes of Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma: A Retrospective Analysis.

Published in:

Oncology, 2025, v. 103, n. 2, p. 94, doi. 10.1159/000541002

By:

Hatanaka, Takeshi;
Saito, Naoto;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Kariyama, Kazuya;
Tani, Joji;
Takaguchi, Koichi;
Itobayashi, Ei;
Ishikawa, Toru;
Toyoda, Hidenori;
Kawata, Kazuhito;
Naganuma, Atsushi;
Yata, Yutaka;
Ohama, Hideko;
Matono, Tomomitsu;
Tada, Fujimasa;
Nouso, Kazuhiro;
Morishita, Asahiro;
Tsutsui, Akemi

Publication type:

Article

Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

Published in:

Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

Published in:

Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

Published in:

Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Tani, Joji;
Hirooka, Masashi;
Takaguchi, Koichi;
Atsukawa, Masanori;
Fukunishi, Shinya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Ochi, Hironori;
Ishikawa, Toru;
Yasuda, Satoshi;
Ogawa, Chikara;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Nishimura, Takashi;
Kakizaki, Satoru

Publication type:

Article

Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

Published in:

Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Toyoda, Hidenori;
Yasuda, Satoshi;
Tsuji, Kunihiko;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Tada, Toshifumi;
Takaguchi, Koichi;
Itobayashi, Ei;
Shimada, Noritomo;
Shibata, Hiroshi;
Tanaka, Takaaki;
Tsutsui, Akemi;
Nagano, Takuya;
Imai, Michitaka;
Nakamura, Shinichiro

Publication type:

Article

Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

Published in:

Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Fukunishi, Shinya;
Ohama, Hideko;
Kawata, Kazuhito

Publication type:

Article

Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko;
Tsutsui, Akemi;
Itokawa, Norio

Publication type:

Article

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 6, p. 334, doi. 10.1159/000502095

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Published in:

Oncology, 2019, v. 97, n. 5, p. 277, doi. 10.1159/000501281

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin Grade.

Published in:

Oncology, 2016, v. 91, n. 3, p. 153, doi. 10.1159/000447061

By:

Hiraoka, atsushi;
Kumada, Takashi;
Nouso, Kazuhiro;
Tsuji, Kunihiko;
Itobayashi, Ei;
Hirooka, Masashi;
Kariyama, Kazuya;
Ishikawa, Toru;
Tada, Toshifumi;
Toyoda, Hidenori;
Kawasaki, Hideki;
Hiasa, Yoichi;
Michitaka, Kojiro

Publication type:

Article

Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma.

Published in:

Oncology, 2015, v. 89, p. 19, doi. 10.1159/000440627

By:

Kariyama, Kazuya;
Wakuta, akiko;
Nishimura, Mamoru;
Kishida, Masayuki;
Oonishi, ayano;
Ohyama, atsushi;
Nouso, Kazuhiro;
Kudo, Masatoshi

Publication type:

Article

Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma with Decompensated Cirrhosis.

Published in:

Oncology, 2011, v. 81, n. 1, p. 39, doi. 10.1159/000331411

By:

Wakuta, Akiko;
Nouso, Kazuhiro;
Kariyama, Kazuya;
Nishimura, Mamoru;
Kishida, Masayuki;
Wada, Nozomu;
Mizushima, Takaaki;
Higashi, Toshihiro;
Tanimoto, Mitsune

Publication type:

Article

Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.

Published in:

Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74

By:

Nouso, Kazuhiro;
Shiota, Shohei;
Fujita, Rio;
Wakuta, Akiko;
Kariyama, Kazuya;
Hiraoka, Atsushi;
Atsukawa, Masanori;
Tani, Joji;
Tada, Toshifumi;
Matsuo, Yu;
Nakamura, Shinichiro;
Tajiri, Kazuto;
Kaibori, Masaki;
Hirooka, Masashi;
Itobayashi, Ei;
Kakizaki, Satoru;
Naganuma, Atsushi;
Ishikawa, Toru;
Hatanaka, Takeshi;
Fukunishi, Shinya

Publication type:

Article

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Toyoda, Hidenori;
Kariyama, Kazuya;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Itobayashi, Ei;
Tsuji, Kunihiko;
Ishikawa, Toru;
Ohama, Hideko;
Tada, Fujimasa;
Nouso, Kazuhiro

Publication type:

Article

Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 181, doi. 10.1159/000514174

By:

Kudo, Masatoshi;
Kawamura, Yusuke;
Hasegawa, Kiyoshi;
Tateishi, Ryosuke;
Kariyama, Kazuya;
Shiina, Shuichiro;
Toyoda, Hidenori;
Imai, Yasuharu;
Hiraoka, Atsushi;
Ikeda, Masafumi;
Izumi, Namiki;
Moriguchi, Michihisa;
Ogasawara, Sadahisa;
Minami, Yasunori;
Ueshima, Kazuomi;
Murakami, Takamichi;
Miyayama, Shiro;
Nakashima, Osamu;
Yano, Hirohisa;
Sakamoto, Michiie

Publication type:

Article

Reply to the Letter "Comment on Regarding Manuscript 'Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies'".

Published in:

2021

By:

Kazuhiro Nouso;
Kazuya Kariyama

Publication type:

Letter to the Editor

What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355

By:

Atsushi Hiraoka;
Takashi Kumada;
Toshifumi Tada;
Kazuya Kariyama;
Joji Tani;
Shinya Fukunishi;
Masanori Atsukawa;
Masashi Hirooka;
Kunihiko Tsuji;
Toru Ishikawa;
Koichi Takaguchi;
Ei Itobayashi;
Kazuto Tajiri;
Noritomo Shimada;
Hiroshi Shibata;
Hironori Ochi;
Kazuhito Kawata;
Satoshi Yasuda;
Hidenori Toyoda;
Hideko Ohama

Publication type:

Article

EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Hiraoka, Atsushi;
Wakuta, Akiko;
Oonishi, Ayano;
Kuzuya, Teiji;
Toyoda, Hidenori;
Tada, Toshifumi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kudo, Masatoshi;
Kumada, Takashi

Publication type:

Article

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Yokohama, Keisuke;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya

Publication type:

Article

Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 50, doi. 10.1159/000502744

By:

Maeda, Masaki;
Saeki, Issei;
Sakaida, Isao;
Aikata, Hiroshi;
Araki, Yasuyuki;
Ogawa, Chikara;
Kariyama, Kazuya;
Nouso, Kazuhiro;
Kitamoto, Mikiya;
Kobashi, Haruhiko;
Sato, Shuichi;
Shibata, Hiroshi;
Joko, Kouji;
Takaki, Shintaro;
Takabatake, Hiroyuki;
Tsutsui, Akemi;
Takaguchi, Koichi;
Tomonari, Tetsu;
Nakamura, Shinichiro;
Nagahara, Takakazu

Publication type:

Article

Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 41, doi. 10.1159/000502479

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Wakuta, Akiko;
Oonishi, Ayano;
Toyoda, Hidenori;
Tada, Toshifumi;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Takaguchi, Koichi;
Tsutsui, Akemi;
Shimada, Noritomo;
Kumada, Takashi

Publication type:

Article

Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

Published in:

Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Kawata, Kazuhito

Publication type:

Article

Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: A multicenter study from Japan.

Published in:

Cancer Science, 2017, v. 108, n. 7, p. 1414, doi. 10.1111/cas.13257

By:

Tada, Toshifumi;
Kumada, Takashi;
Toyoda, Hidenori;
Tsuji, Kunihiko;
Hiraoka, Atsushi;
Itobayashi, Ei;
Nouso, Kazuhiro;
Kariyama, Kazuya;
Ishikawa, Toru;
Hirooka, Masashi;
Hiasa, Yoichi

Publication type:

Article

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Nagano, Takuya;
Itokawa, Norio;
Hayama, Korenobu

Publication type:

Article

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.

Published in:

Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Takaguchi, Koichi;
Atsukawa, Masanori;
Itobayashi, Ei;
Tsuji, Kunihiko;
Tajiri, Kazuto;
Hirooka, Masashi;
Shimada, Noritomo;
Shibata, Hiroshi;
Ishikawa, Toru;
Ochi, Hironori;
Tada, Toshifumi;
Toyoda, Hidenori;
Nouso, Kazuhiro;
Tsutsui, Akemi;
Itokawa, Norio;
Imai, Michitaka;
Joko, Kouji

Publication type:

Article

Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.

Published in:

Journal of Gastroenterology & Hepatology, 2005, v. 20, n. 4, p. 583, doi. 10.1111/j.1440-1746.2005.03726.x

By:

Uematsu, Shuji;
Higashi, Toshihiro;
Nouso, Kazuhiro;
Kariyama, Kazuya;
Nakamura, Shin-Ichiro;
Suzuki, Mayumi;
Nakatsukasa, Harushige;
Kobayashi, Yoshiyuki;
Hanafusa, Tadashi;
Tsuji, Takao;
Shiratori, Yasushi

Publication type:

Article

Letter: rising incidence and poor survival in patients with non‐viral HCC – better HCC surveillance and treatment for alcohol‐associated and non‐alcohol fatty liver diseases are needed. Authors' reply.

Published in:

Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 363, doi. 10.1111/apt.17361

By:

Toyoda, Hidenori;
Kariyama, Kazuya;
Hiraoka, Atsushi

Publication type:

Article

Editorial: non‐viral hepatocellular carcinoma surveillance—an increasingly severe public health issue. Authors' reply.

Published in:

2022

By:

Toyoda, Hidenori;
Kariyama, Kazuya;
Hiraoka, Atsushi

Publication type:

Editorial

Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.

Published in:

Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 694, doi. 10.1111/apt.17088

By:

Toyoda, Hidenori;
Kariyama, Kazuya;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Hatanaka, Takeshi;
Naganuma, Atsushi;
Yasuda, Satoshi;
Nouso, Kazuhiro;
Kakizaki, Satoru;
Kumada, Takashi;
Innes, Hamish;
Johnson, Philip J.

Publication type:

Article

Identification of risk groups for advanced liver fibrosis in the general population using the Fibrosis‐3 index.

Published in:

JGH Open, 2024, v. 8, n. 7, p. 1, doi. 10.1002/jgh3.70010

By:

Kariyama, Kazuya;
Kawanaka, Miwa;
Nouso, Kazuhiro;
Wakuta, Akiko;
Shiota, Shohei;
Kurisu, Akemi;
Sugiyama, Aya;
Akita, Tomoyuki;
Kumada, Takashi;
Tanaka, Junko

Publication type:

Article

Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

Published in:

Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Ogawa, Chikara;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 949, doi. 10.1111/jgh.16884

By:

Matono, Tomomitsu;
Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Nishikawa, Hiroki;
Tanaka, Kazunari;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Koshiyama, Yuichi;
Toyoda, Hidenori;
Ogawa, Chikara;
Hatanaka, Takeshi

Publication type:

Article

Reliable Performance of mALBI Grade‐Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First‐Line Treatment: Comparative Analysis of 13 Risk Models.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 930, doi. 10.1111/jgh.16871

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents.

Published in:

Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 7, p. 1394, doi. 10.1111/jgh.16553

By:

Ohama, Hideko;
Hiraoka, Atsushi;
Tada, Toshifumi;
Kariyama, Kazuya;
Itobayashi, Ei;
Tsuji, Kunihiko;
Ishikawa, Toru;
Toyoda, Hidenori;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Tada, Fujimasa;
Tanaka, Hironori;
Nakamura, Shinichiro;
Nouso, Kazuhiro;
Tanaka, Kazunari;
Kumada, Takashi

Publication type:

Article

mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response.

Published in:

Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 6, p. 1164, doi. 10.1111/jgh.16512

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Kariyama, Kazuya;
Yasuda, Satoshi;
Tada, Fujimasa;
Ohama, Hideko;
Nouso, Kazuhiro;
Matono, Tomomitsu;
Nakamura, Shinichiro;
Toyoda, Hidenori

Publication type:

Article

Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

Published in:

Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1389, doi. 10.1111/jgh.16225

By:

Tada, Toshifumi;
Kumada, Takashi;
Hiraoka, Atsushi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishimura, Takashi;
Hatanaka, Takeshi;
Kakizaki, Satoru

Publication type:

Article

Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.

Published in:

Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Kariyama, Kazuya;
Tada, Toshifumi;
Tani, Joji;
Fukunishi, Shinya;
Atsukawa, Masanori;
Hirooka, Masashi;
Tsuji, Kunihiko;
Ishikawa, Toru;
Takaguchi, Koichi;
Itobayashi, Ei;
Tajiri, Kazuto;
Shimada, Noritomo;
Shibata, Hiroshi;
Ochi, Hironori;
Kawata, Kazuhito;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ohama, Hideko

Publication type:

Article

Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma.

Published in:

Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 3, p. 695, doi. 10.1111/jgh.13586

By:

Nouso, Kazuhiro;
Kariyama, Kazuya;
Nakamura, Shinichiro;
Oonishi, Ayano;
Wakuta, Akiko;
Oyama, Atsushi;
Ako, Soichiro;
Dohi, Chihiro;
Wada, Nozomu;
Morimoto, Yuki;
Takeuchi, Yasuto;
Kuwaki, Kenji;
Onishi, Hideki;
Ikeda, Fusao;
Shiraha, Hidenori;
Takaki, Akinobu;
Okada, Hiroyuki

Publication type:

Article

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.

Published in:

2013

By:

Izumi, Namiki;
Asahina, Yasuhiro;
Kurosaki, Masayuki;
Yamada, Gotaro;
Kawai, Tsutomu;
Kajiwara, Eiji;
Okamura, Yukishige;
Takeuchi, Takayuki;
Yokosuka, Osamu;
Kariyama, Kazuya;
Toyoda, Joji;
Inao, Mie;
Tanaka, Eiji;
Moriwaki, Hisataka;
Adachi, Hiroshi;
Katsushima, Shinji;
Kudo, Masatoshi;
Takaguchi, Kouichi;
Hiasa, Yoichi;
Chayama, Kazuaki

Publication type:

journal article

Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study.

Published in:

Journal of Gastroenterology, 2013, v. 48, n. 3, p. 382, doi. 10.1007/s00535-012-0641-9

By:

Izumi, Namiki;
Asahina, Yasuhiro;
Kurosaki, Masayuki;
Yamada, Gotaro;
Kawai, Tsutomu;
Kajiwara, Eiji;
Okamura, Yukishige;
Takeuchi, Takayuki;
Yokosuka, Osamu;
Kariyama, Kazuya;
Toyoda, Joji;
Inao, Mie;
Tanaka, Eiji;
Moriwaki, Hisataka;
Adachi, Hiroshi;
Katsushima, Shinji;
Kudo, Masatoshi;
Takaguchi, Kouichi;
Hiasa, Yoichi;
Chayama, Kazuaki

Publication type:

Article

Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study.

Published in:

Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 269, doi. 10.1007/s40121-020-00364-9

By:

Tada, Toshifumi;
Kumada, Takashi;
Okushin, Hiroaki;
Tani, Joji;
Takaguchi, Koichi;
Tsutsui, Akemi;
Toyoda, Hidenori;
Yasuda, Satoshi;
Dohmen, Kazufumi;
Hiraoka, Atsushi;
Michitaka, Kojiro;
Nouso, Kazuhiro;
Kariyama, Kazuya;
Kim, Soo Ryang;
Kim, Soo Ki;
Fujioka, Shinichi;
Mikami, Shigeru;
Watanabe, Yuto;
Tamai, Tsutomu;
Atsukawa, Masanori

Publication type:

Article

Factors linked to hepatocellular carcinoma development beyond 10 years after viral eradication in patients with hepatitis C virus.

Published in:

Journal of Viral Hepatitis, 2022, v. 29, n. 10, p. 919, doi. 10.1111/jvh.13728

By:

Takashi Kumada;
Hidenori Toyoda;
Satoshi Yasuda;
Takanori Ito;
Kunihiko Tsuji;
Shinichi Fujioka;
Atsushi Hiraoka;
Kazuya Kariyama;
Kazuhiro Nouso;
Toru Ishikawa;
Tsutomu Tamai;
Toshifumi Tada;
Junko Tanaka

Publication type:

Article

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.

Published in:

Cancers, 2019, v. 11, n. 2, p. 203, doi. 10.3390/cancers11020203

By:

Kariyama, Kazuya;
Nouso, Kazuhiro;
Toyoda, Hidenori;
Tada, Toshifumi;
Hiraoka, Atsushi;
Tsuji, Kunihiko;
Itobayashi, Ei;
Ishikawa, Toru;
Wakuta, Akiko;
Oonishi, Ayano;
Kumada, Takashi;
Kudo, Masatoshi

Publication type:

Article

Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma.

Published in:

Cancer Medicine, 2025, v. 14, n. 2, p. 1, doi. 10.1002/cam4.70618

By:

Naganuma, Atsushi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hatanaka, Takeshi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Toyoda, Hidenori;
Ogawa, Chikara;
Nishikawa, Hiroki;
Nishimura, Takashi;
Kawata, Kazuhito;
Kosaka, Hisashi

Publication type:

Article

Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.

Published in:

Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726

By:

Hatanaka, Takeshi;
Kakizaki, Satoru;
Hiraoka, Atsushi;
Tada, Toshifumi;
Hirooka, Masashi;
Kariyama, Kazuya;
Tani, Joji;
Atsukawa, Masanori;
Takaguchi, Koichi;
Itobayashi, Ei;
Fukunishi, Shinya;
Tsuji, Kunihiko;
Ishikawa, Toru;
Tajiri, Kazuto;
Ochi, Hironori;
Yasuda, Satoshi;
Toyoda, Hidenori;
Ogawa, Chikara;
Yokohama, Keisuke;
Nishikawa, Hiroki

Publication type:

Article